Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Korro Bio (KRRO) Other Non Operating Income (2019 - 2025)

Korro Bio (KRRO) has disclosed Other Non Operating Income for 6 consecutive years, with $1.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Non Operating Income fell 48.51% year-over-year to $1.2 million, compared with a TTM value of $6.2 million through Sep 2025, down 22.6%, and an annual FY2024 reading of $8.5 million, up 149.93% over the prior year.
  • Other Non Operating Income was $1.2 million for Q3 2025 at Korro Bio, down from $1.4 million in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $2.3 million in Q2 2024 and bottomed at -$227000.0 in Q2 2022.
  • Average Other Non Operating Income over 5 years is $949611.1, with a median of $721000.0 recorded in 2023.
  • Peak annual rise in Other Non Operating Income hit 15525.0% in 2022, while the deepest fall reached 22600.0% in 2022.
  • Year by year, Other Non Operating Income stood at -$4000.0 in 2021, then skyrocketed by 15575.0% to $619000.0 in 2022, then skyrocketed by 136.83% to $1.5 million in 2023, then soared by 32.61% to $1.9 million in 2024, then crashed by 39.51% to $1.2 million in 2025.
  • Business Quant data shows Other Non Operating Income for KRRO at $1.2 million in Q3 2025, $1.4 million in Q2 2025, and $1.6 million in Q1 2025.